Advertisement

Immunoprecipitation of Cdk–Cyclin Complexes for Determination of Kinase Activity

  • Edurne Gallastegui
  • Oriol BachsEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1336)

Abstract

Cyclin-dependent kinases (Cdks) belong to a family of key regulators of cell division cycle and transcription. The activity of some of them is deregulated in tumor cells and to find specific inhibitors is an important goal to be achieved. We report here the current methods to determine their in vitro activity in order to facilitate the identification of specific inhibitors. Mainly, the activity can be determined by using immunoprecipitates from cell samples with antibodies against specific Cdks as a source of the enzymes.

Key words

Cdk2 Cdk4 Cdk6 Cdk1 Cyclin A Cyclin B Cyclin D Kinase assay 

References

  1. 1.
    Malumbres M (2014) Cyclin-dependent kinases. Genome Biol 15:122–131PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, Morgan DO, Tsai L-H, Wolgemuth DJ (2009) Cyclin-dependent kinases: a family portrait. Nat Cell Biol 11:1275–1276PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Cao L, Chen F, Yang X, Xu W, Xie J, Yu L (2014) Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages. BMC Evol Biol 14:10PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13:261–291PubMedCrossRefGoogle Scholar
  5. 5.
    Mateo F, Vidal-Laliena M, Canela N, Zecchin A, Martínez-Balbás M, Agell N, Giacca M, Pujol MJ, Bachs O (2009) The transcriptional co-activator PCAF regulates Cdk2 activity. Nucleic Acids Res 37:7072–7084PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Echalier A, Endicott JA, Noble MEM (2010) Recent developments in cyclin-dependent kinase biochemical and structural studies. Biochim Biophys Acta 1804:511–519PubMedCrossRefGoogle Scholar
  7. 7.
    Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30:630–641PubMedCrossRefGoogle Scholar
  8. 8.
    Russo AA, Jeffrey PD, Patten AK, Massagué J, Pavletich NP (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325–331PubMedCrossRefGoogle Scholar
  9. 9.
    Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287:821–828PubMedCrossRefGoogle Scholar
  10. 10.
    Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel E-M, Waddell MB, Jäkel H, Kullmann M, Kriwacki RW, Hengst L (2007) Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269–280PubMedCrossRefGoogle Scholar
  11. 11.
    Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan C-K, Hengst L, Slingerland J (2007) p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128:281–294PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2016

Authors and Affiliations

  1. 1.Department of Cell Biology, Immunology and NeurosciencesUniversity of BarcelonaBarcelonaSpain
  2. 2.Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)BarcelonaSpain

Personalised recommendations